Club Hernie association represented by Dr Gillion, in his capacity as President
Montrouge, 92120, France
NCT Number: NCT02206828
The aim of this Observational Registry Study is to assess the short- and long-term clinical outcomes following the use of Symbotex™ Composite Mesh in primary and incisional abdominal wall hernia surgeries by open or laparoscopic approach, according to the Instruction for use (IFU).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montrouge, 92120, France
This is an observational multicenter registry study. One hundred consecutive, adult patients scheduled for primary and incisional abdominal wall hernia surgeries using Symbotex™ Composite Mesh will be reported in the ClubHernie online database, with standard data captured of all preoperative, perioperative and post-operative data, for patient's outcomes measurements.
Primary Objective:
Evaluate the incidence of peri-operative and post-operative complications, with postoperative evaluations occurring, at discharge , 1 week (D1 and D8 follow up), 1 month (D30 follow up), 1 year and 2 year follow up after primary and incisional abdominal wall hernia surgeries using Symbotex™ Composite Mesh by open or laparoscopic approach (such as anticipated device related complications such as pain, recurrence, complications related to adhesions, wound complications, other postoperative complications, (SAE).
This online database consists of a systematic and consecutive data entry of all patients treated for Inguinal Hernia and Ventral Hernia by the 30 French surgeon members, with standard data captured of all preoperative, perioperative and post-operative data.
The database is required to be completed anonymously. Quality data control of all data captured into the online database will be performed by coherence analysis by Club Hernie authorized representative;A statistical analysis plan will be developed by Covidien.
Study reported device-related events will be reviewed periodically to assess for any potential trends
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Various (measured at 1 month, 1 Year & 2 Year)
Primary endpoint focuses on complications (including recurrence) occurring during procedure, and in short, mid and long-term (measured at 1 month, 1 year and 2 year follow-up respectively) following ventral hernia repair.
All peri-, intra- and post- operative complications
Time frame: Various ( Baseline Day 0, Day 1, Day 8, Month 1, Month 3, 1 year , 2 year
Pain assessment measured with VAS* score
*VAS: The postoperative pain is assessed using a 0-10 Visual Analogue Scale. Worst pain experienced over the last 24 hours. Mild pain for VAS score between 0 and 3; Moderate pain for VAS score > 3 and > 6 ; Severe pain for VAS scores > 6
Time frame: Various ( 1 Month, 1 year and 2 Year follow up)
Quality of Life of patients treated for ventral hernia For long-term follow up, two sets of self-administered Quality of Life (QOL) and patient satisfaction questionnaires were administered by phone call at 1 year and 2 year follow-up.
Time frame: Various (1 year and 2 year)
Patient satisfaction For long-term follow up, two sets of self-administered Quality of Life (QOL) and patient satisfaction questionnaires were administered by phone call at 1 year and 2 year follow-up.
Time frame: Day 0 Baseline
Mesh ease of use assessed by surgeons using Symbotex™ Composite Mesh for Patients treated for ventral hernia
Time frame: Day 0 Baseline
ease of use / mesh Handling Mesh ease of use assessed by surgeons using Symbotex™ Composite Mesh for Patients treated for ventral hernia- Participant reflect surgeon who asses the feature of the mesh (for example, 68 surgeons agree that marking eases to place the mesh, 34 surgeons agree that the mesh is conformable to the anatomy etc..
Time frame: Baseline Day 0
Surgical technique approach for patients treated for ventral hernia with Symbotex™ Composite Mesh
Time frame: Baseline Day 0
Operative Time (min) for patients treated for ventral hernia
Time frame: Baseline Day 0
Hospital stay (Days) for patients treated for ventral hernia with Symbotex Composite mesh device
Medtronic - MITG
Industry
Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair
Acronym: SymCHro
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05142761
Ventral Incisional Hernia
Cleveland, Ohio, United States
View Trial DetailsNCT02129140
Ventral Incisional Hernia
New York, United States
View Trial DetailsNCT03043079
Ventral Incisional Hernia
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01325792
Ventral Incisional Hernia
San Diego, California, United States
View Trial Details